GENERIC LISTING STANDARDS FOR ETFS RELYING ON RULE 6C-11 APPROVED -
The US Securities and Exchange Commission (SEC) has approved generic listing standards proposed by NYSE Arca, Inc., Cboe BZX Exchange, Inc., and The Nasdaq...more
5/7/2020
/ Coronavirus/COVID-19 ,
Derivatives ,
Disclosure Requirements ,
ETFs ,
Exchange-Traded Products ,
Financial Markets ,
Investment Management ,
Listing Standards ,
Relief Measures ,
Securities and Exchange Commission (SEC) ,
Securities Regulation ,
Securities Transactions
New standards are expected to simplify and expedite the process of launching an actively managed ETF.
On July 22, the US Securities and Exchange Commission (SEC) issued orders approving proposals by Bats BZX Exchange,...more
Withdrawal comes within days of SEC Chair White and Commissioner Aguilar issuing public statements regarding ETFs.
On October 19, the US Securities and Exchange Commission (SEC) published a notice stating that NYSE Arca,...more
10/29/2015
/ ETFs ,
Exchange-Traded Products ,
Investor Advisory Committee ,
Liquidity ,
Listing Standards ,
NYSE ,
Pricing ,
Proposed Regulation ,
Public Comment ,
Securities and Exchange Commission (SEC) ,
Transparency
The SEC needs more time to consider generic listing standards for active ETFs.
On September 2, the US Securities and Exchange Commission (SEC) published a notice (Notice) designating a longer period of time to consider...more
Growth in the ETP industry has led the SEC to seek public comment on a variety of topics related to the listing and trading of ETP shares.
On June 12, the US Securities and Exchange Commission (SEC) issued a release (the...more
7/2/2015
/ Arbitrage ,
Broker-Dealer ,
Exchange-Traded Products ,
Exemptive Relief ,
Investment Adviser ,
Investors ,
Listing Standards ,
Market Pricing ,
No-Action Relief ,
Public Comment ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act
Although the proposed listing standards could significantly reduce regulatory barriers, commissioner dissent in exchange-traded product order underscores regulatory concerns about novel products....more